Vanguard Global Advisers
NNVC icon

Vanguard Global Advisers’s NanoViricides NNVC Stock Holding History

Vanguard Global Advisers’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.83K Hold
3,712
– – ﹤0.01% 3590
2026
Q2 		$5.12K Hold
3,712
– – ﹤0.01% 3550
2026
Q1 		$3.38K Buy
+3,712
New +$3.88K ﹤0.01% 3585

Other funds holding NNVC

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Miller Financial Services
Miller Financial Services Marshall, Michigan $132M AUM 10.64% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Empowered Funds
Empowered Funds Havertown, Pennsylvania $21.7B AUM 41.23% 1-Year Est. Return

Vanguard Global Advisers's NNVC Position: Q3 2026 in Review

Vanguard Global Advisers held its NanoViricides (NNVC) position steady in Q3 2026 at 3,712 shares worth $4.83K. The position accounts for ﹤0.01% of the portfolio, ranked #3590.

Vanguard Global Advisers first reported a position in NNVC in Q1 2026 and has held it in 3 quarters since. The position peaked at $5.12K in Q2 2026. 38 funds tracked by Wall St. Rank hold NNVC as of Q3 2026.

  • Vanguard Global Advisers held 3,712 shares of NanoViricides worth $4.83K as of Q3 2026.
  • Vanguard Global Advisers left its NanoViricides share count unchanged in Q3 2026.
  • NanoViricides made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #3590 holding.
  • Vanguard Global Advisers first reported a position in NanoViricides in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Global Advisers's NanoViricides position peaked at $5.12K in Q2 2026.
  • 38 funds tracked by Wall St. Rank held NanoViricides as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.